Discover
BrainX Talks
29 Episodes
Reverse
Amol M. Joshi, PhD, is the Thomas H. Davis Professor in Business at Wake Forest University (WFU). He holds a joint faculty appointment as an Associate Professor of Strategic Management in the WFU School of Business and as an Associate Professor of Innovation & Commercialization in the WFU School of Medicine.
Dr. Joshi is an inventor who helps others reinvent themselves. His passion is guiding aspiring entrepreneurs, executives, and students of all levels to pursue their business dreams. He has trained startup founders, corporate managers, and industry leaders in the US, Austria, Denmark, and Vietnam.
A recognized expert on innovation, his interdisciplinary research examines how inventors create and commercialize new technologies and launch and fund new ventures. With a 13-year prior career as an engineer and entrepreneur in venture capital-funded startups in Silicon Valley, Dr. Joshi co-invented two patents for AI-based voice assistant products. He co-founded BeVocal, a speech recognition software startup acquired by Nuance Communications, and served as VP of Sales & Marketing from 1999 to 2003.
Dr. Joshi has advised Federal agencies including NASA, NSF, NIH, and the US Department of Energy on national innovation policies and R&D grant programs for small businesses. Dr. Joshi earned a PhD in Business Administration from UNC Chapel Hill, an MBA and MS in Engineering Sciences from Dartmouth College, and a BS in Electrical Engineering from Georgia Tech with highest honors.
In this episode, we feature Dr. Kamal Maheshwari, MD, MPH, FASA.He is a distinguished anesthesiologist with extensive experience in clinical practice, research, and innovation. He completed his medical education and anesthesia training at the University of Delhi, India (1995-2004) before relocating to the United States in 2005 for advanced training in anesthesiology. From 2009 to 2023, Dr. Maheshwari worked at the Cleveland Clinic Foundation, where he established himself as a renowned clinician, researcher, and innovator. In 2015, he earned a Master of Public Health (MPH) from the Johns Hopkins Bloomberg School of Public Health, specializing in health policy and management. Additionally, he received a certificate in Quality Patient Safety and Outcomes Research from the same institution. In 2016, Dr. Maheshwari founded the Center of Perioperative Intelligence at the Cleveland Clinic Foundation, focusing on artificial intelligence applications in perioperative medicine. His research portfolio includes over 100 peer-reviewed papers, book chapters published in major academic journals, primarily evaluating the role of advanced technologies, predictive algorithms, machine learning, and artificial intelligence in developing decision support systems to enhance perioperative care and outcomes. Dr. Maheshwari has served as an advisor to several health technology firms, including Edwards Lifesciences and Philips Healthcare, contributing to the development of life-saving medical devices and solutions. Dr. Maheshwari is also the founding partner of BrainX and BrainX Community, both of which being AI in healthcare companies based out of US.Driven by a commitment to global health improvement, Dr. Maheshwari founded Roojh Health, an organization dedicated to enhancing healthcare in developing countries. The primary mission of Roojh Health is to empower doctors and patients with high-quality information for better decision-making.
Dr. Rashidi combines his passion for patient care, research and education with his unique training in bioinformatics and machine learning (ML) to create innovative new tools (i.e. MILO, STNG, Pitt-GPT, etc.) and resources (Hematology Outlines, Cleveland Clinic's AI course, etc.) that improve clinical practice, research and education.
His experience in ML dates back to his graduate years at UCSD which subsequently allowed him to serve as the principal author and editor of several popular bioinformatics textbooks. This background has also enabled him to develop various novel AI-ML platforms. Before joining U Pitt / UPMC, he served as the founding director of Cleveland Clinic’s PLMI Center for AI and Data Science & Vice Chair of Technology Innovation & Computational Pathology, and before that he served as the Director of AI for University of California Davis Medical Center and Professor & Vice chair of informatics, leading a large number of AI studies with numerous collaborators from various prominent institutions. These experiences and studies have also led to numerous products (most recent of which bring the on-prem LLM framework Pitt-GPT) & several filed patents (e.g. the University of California IP MILO: Machine Intelligence Learning Optimizer, the proprietary Automated ML platform & it’s suite of 6 complimentary separate unique Data Science Apps & Cleveland Clinic’s new automated synthetic data generator and Validation platform STNG, Synthetic Tabular Neural Generator) along with a large number of manuscripts in which he serves as corresponding author. These products have been licensed to several industry and academic institutions & serving as a powerful suite of data science tools for a large number of clinical, quality and educational projects while also starting to help optimize and expedite data access needs for all investigators.
In addition to the above, Dr. Rashidi is also a well known educator with numerous teaching awards who has created some of the AppStore’s most popular hematology Apps along with Cleveland Clinic’s most recent AI-ML course (launched Cleveland Clinic wide in Jan 2024). He is also the co-founder and senior editor of HematologyOutlines, a very popular digital hematology atlas that is used internationally and endorsed by the American Society of Clinical Pathology.
Dr. Rashidi’s efforts in the AI-ML & digital space are internationally recognized, as evidenced by his continuous invited talks at prominent conferences & institutions, his various journal AI/ML editorial & reviewer roles, his multitude of key invited review articles & his continued national committee roles within this space.
Indira Negi is a consultant with Global Health Labs working on AI ultrasound focused on Obstetrics in India and next steps for pediatric lung ultrasound, alongside the Gates Foundation.
Before this she was a Senior Advisor and Deputy Director at the Bill and Melinda Gates Foundation and lead efforts to improve maternal and newborn health by investing in innovative devices and software that can help with early diagnosis and reduce risk during pregnancy and labor.
She worked at Intel for over a decade, leading the sensors engineering team for wearable devices, serving in engineering and business roles across several groups, and eventually leading strategy and planning for the Health and Life Science business unit. She also advised Intel’s corporate venture arm on health technology investments.
Before joining the foundation, Indira was the vice president of product management at AliveCor, an ECG medical devices company focused on cardiology services. She holds five patents.
Indira gets her sense of purpose from creating new technology and making existing technology more accessible to reduce suffering. She gets her joy from spending time in nature, being with her dogs, family, and friends, and building things. Indira trained as an electrical engineer.
Links
https://www.linkedin.com/in/indiranegi/
indiranegi.com
Welcome to BrainX AI in Medicine Podcast series, where we bring in leaders within fields of AI and Medicine to discuss their cutting-edge research, explore boundaries of current knowledge, and provide insightful commentary on how to effectively lead the AI revolution in Medicine.
Today's guest is Vivek Natarajan, who is a Research Scientist at Google leading research at the intersection of large language models (LLMs) and biomedicine. In particular, Vivek is the lead researcher behind Med-PaLM and Med-PaLM 2, which were the first AI systems to obtain passing and expert level scores on US Medical License exam questions respectively. Med-PaLM was recently published in Nature and has been featured in The Scientific American, Wall Street Journal, The Economist, among many others.
More recently, Vivek also led the development of Med-PaLM M, the first demonstration of a generalist biomedical AI system and AMIE, a research AI system, which surpassed Primary Care Physicians on multiple axes pertaining to diagnostic dialogue in an randomized study conducted in the style of a virtual Objective Structured Clinical Examination (OSCE). Over the years, Vivek’s research has been published in well-regarded journals and conferences like Nature, Nature Medicine, Nature Biomedical Engineering, JMLR, CVPR, and NeurIPS. It also forms the basis for several regulated medical device products under clinical trials at Google, including the NHS AI award winning breast cancer detection system Mammo Reader and the skin condition classification system DermAssist.




